person · Reporting owner

COWARD D SCOTT

Disclosed activity across 2 companies

Tapewire entity: 56623
SEC CIK: 0001247296

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Humacyte, Inc.HUMA · Entity 6478	Director	October 06, 2026	October 07, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Humacyte, Inc.

Report date October 06, 2026 · Filed October 07, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.48 · Expires 2036-10-06	Direct	125,000	Reported balance After 2026-10-06 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-10-06 · Grant · Acquired 125,000 · Balance 125,000 F1: The first 25% of the option becomes exercisable on October 6, 2027, after which 1/48 of the option becomes exercisable on the 6th day of each month thereafter, with the option becoming fully vested on October 6, 2030.

Filing footnotes · ownership attribution and instrument terms

F1: The first 25% of the option becomes exercisable on October 6, 2027, after which 1/48 of the option becomes exercisable on the 6th day of each month thereafter, with the option becoming fully vested on October 6, 2030.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

EXACT SCIENCES CORP

Report date March 23, 2026 · Filed March 23, 2026

Section 16 reporting ended · disclosed 2026-03-23. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Ending reported balance After 2026-03-23 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2026-03-23 · Disposition to issuer · Disposed 52,164 · Balance 5,398 F1: On March 23, 2026, pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of November 19, 2025, by and among Exact Sciences Corporation, a Delaware corporation (the "Issuer"), Abbott Laboratories, an Illinois corporation ("Parent"), and Badger Merger Sub I, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a direct, wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), on the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), issued and outstanding immediately prior to the Effective Time, with certain exceptions, was converted into the right to receive $105.00 in cash, without interest (the "Merger Consideration"). Row 2 · 2026-03-23 · Disposition to issuer · Disposed 5,398 · Balance 0 F2: At the Effective Time, each share of Common Stock subject to vesting, repurchase or other lapse restriction and that was granted under an Issuer stock plan and outstanding as of immediately prior to the Effective Time was deemed to be fully vested and cancelled and converted into the right to receive the Merger Consideration, less any applicable tax withholding.
Common StockSEC Table I · non-derivative	IndirectHeld in 401(k) Plan	Reported balance After 2026-03-23 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2026-03-23 · Disposition to issuer · Disposed 4,694 · Balance 0 F1: On March 23, 2026, pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of November 19, 2025, by and among Exact Sciences Corporation, a Delaware corporation (the "Issuer"), Abbott Laboratories, an Illinois corporation ("Parent"), and Badger Merger Sub I, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a direct, wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), on the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), issued and outstanding immediately prior to the Effective Time, with certain exceptions, was converted into the right to receive $105.00 in cash, without interest (the "Merger Consideration").
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $44.37	Direct	Reported balance After 2026-03-23 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2026-03-23 · Disposition to issuer · Disposed 4,175 · Balance 0 F4: At the Effective Time, each option to purchase shares of Common Stock granted under an Issuer stock plan and outstanding and unexercised as of immediately prior to the Effective Time was cancelled and, in the case of any such option the per-share exercise price of which was less than the Merger Consideration, converted into the right to receive a cash payment equal to the number of shares of Common Stock for which such option was exercisable multiplied by the excess of the Merger Consideration over the per-share exercise price of such option, less any applicable tax withholding F3: These options became exercisable on February 27, 2022.
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $92.62	Direct	Reported balance After 2026-03-23 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2026-03-23 · Disposition to issuer · Disposed 10,786 · Balance 0 F4: At the Effective Time, each option to purchase shares of Common Stock granted under an Issuer stock plan and outstanding and unexercised as of immediately prior to the Effective Time was cancelled and, in the case of any such option the per-share exercise price of which was less than the Merger Consideration, converted into the right to receive a cash payment equal to the number of shares of Common Stock for which such option was exercisable multiplied by the excess of the Merger Consideration over the per-share exercise price of such option, less any applicable tax withholding F5: These options became exercisable on February 26, 2023.
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $98.18	Direct	Reported balance After 2026-03-23 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2026-03-23 · Disposition to issuer · Disposed 12,875 · Balance 0 F4: At the Effective Time, each option to purchase shares of Common Stock granted under an Issuer stock plan and outstanding and unexercised as of immediately prior to the Effective Time was cancelled and, in the case of any such option the per-share exercise price of which was less than the Merger Consideration, converted into the right to receive a cash payment equal to the number of shares of Common Stock for which such option was exercisable multiplied by the excess of the Merger Consideration over the per-share exercise price of such option, less any applicable tax withholding F6: These options became exercisable on February 14, 2024.

Filing footnotes · ownership attribution and instrument terms

F1: On March 23, 2026, pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of November 19, 2025, by and among Exact Sciences Corporation, a Delaware corporation (the "Issuer"), Abbott Laboratories, an Illinois corporation ("Parent"), and Badger Merger Sub I, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a direct, wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), on the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), issued and outstanding immediately prior to the Effective Time, with certain exceptions, was converted into the right to receive $105.00 in cash, without interest (the "Merger Consideration").

F2: At the Effective Time, each share of Common Stock subject to vesting, repurchase or other lapse restriction and that was granted under an Issuer stock plan and outstanding as of immediately prior to the Effective Time was deemed to be fully vested and cancelled and converted into the right to receive the Merger Consideration, less any applicable tax withholding.

F3: These options became exercisable on February 27, 2022.

F4: At the Effective Time, each option to purchase shares of Common Stock granted under an Issuer stock plan and outstanding and unexercised as of immediately prior to the Effective Time was cancelled and, in the case of any such option the per-share exercise price of which was less than the Merger Consideration, converted into the right to receive a cash payment equal to the number of shares of Common Stock for which such option was exercisable multiplied by the excess of the Merger Consideration over the per-share exercise price of such option, less any applicable tax withholding

F5: These options became exercisable on February 26, 2023.

F6: These options became exercisable on February 14, 2024.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
February 14, 2022 Filed Feb 16, 2022 19:58 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionRestricted Stock Units · Derivative	3,972	$0.00	$0.00	Disclosure SEC source: 0001209191-22-010368 · doc4.xml · derivative · entry 5 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,944 Underlying: Common Stock · 3,972 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Represents a restricted stock unit award that partially vested on February 14, 2022. The restricted stock units vest in four equal annual installments beginning on February 14, 2021. F6 · derivative.expiration_date: Represents a restricted stock unit award that partially vested on February 14, 2022. The restricted stock units vest in four equal annual installments beginning on February 14, 2021. Read SEC document
February 14, 2022 Filed Feb 16, 2022 19:58 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionCommon Stock	3,972	$78.33	$311,126.76	Disclosure SEC source: 0001209191-22-010368 · doc4.xml · nonDerivative · entry 2 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document
April 30, 2021 Filed Feb 16, 2022 19:58 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	GrantCommon Stock	328	$64.74	$21,234.72	Disclosure SEC source: 0001209191-22-010368 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,629 F1 · shares: Represents shares of common stock purchased through Employee Stock Purchase Plan. Read SEC document
March 03, 2021 Filed Mar 5, 2021 16:48 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	SaleCommon Stock	2,664	$135.02	$359,693.28	Disclosure SEC source: 0001209191-21-018258 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,301 F1 · shares: The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document
March 02, 2021 Filed Mar 3, 2021 20:30 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	SaleCommon Stock	1,765	$140.31	$247,647.15	Disclosure SEC source: 0001209191-21-017509 · doc4.xml · nonDerivative · entry 3 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,965 F3 · shares: The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan. F4 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 8,038 shares, Mr. Coward also holds, in the aggregate, an additional 60,294 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document
March 02, 2021 Filed Mar 3, 2021 20:30 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	SaleCommon Stock	2,361	$138.42	$326,809.62	Disclosure SEC source: 0001209191-21-017509 · doc4.xml · nonDerivative · entry 2 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,730 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on March 1, 2021. Read SEC document
March 01, 2021 Filed Mar 2, 2021 18:56 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionStock Option (right to buy) · Derivative	4,175	$0.00 Strike: $44.37	$0.00	Disclosure SEC source: 0001209191-21-016471 · doc4.xml · derivative · entry 7 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,175 Underlying: Common Stock · 4,175 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: These options vested and became exercisable in four equal annual installments beginning on February 27, 2019. F8 · derivative.expiration_date: These options vested and became exercisable in four equal annual installments beginning on February 27, 2019. Read SEC document
March 01, 2021 Filed Mar 2, 2021 18:56 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	SaleCommon Stock	4,175	$136.79	$571,098.25	Disclosure SEC source: 0001209191-21-016471 · doc4.xml · nonDerivative · entry 4 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,066 F4 · shares: The sales reported in this field were effected pursuant to a Rule 10b5-1 trading plan. F5 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 7,139 shares, Mr. Coward also holds, in the aggregate, an additional 65,319 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document
March 01, 2021 Filed Mar 2, 2021 18:56 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionCommon Stock	4,175	$44.37	$185,244.75	Disclosure SEC source: 0001209191-21-016471 · doc4.xml · nonDerivative · entry 3 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents shares of common stock received upon exercise of a stock option award. Read SEC document
March 01, 2021 Filed Mar 2, 2021 18:56 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	SaleCommon Stock	1,498	$137.44	$205,885.12	Disclosure SEC source: 0001209191-21-016471 · doc4.xml · nonDerivative · entry 2 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,066 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 26, 2021. Read SEC document
March 01, 2021 Filed Mar 3, 2021 20:30 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionRestricted Stock Units · Derivative	5,025	$0.00	$0.00	Disclosure SEC source: 0001209191-21-017509 · doc4.xml · derivative · entry 5 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,025 Underlying: Common Stock · 5,025 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Represents a restricted stock unit award granted on February 27, 2018 that partially vested on March 1, 2021. The restricted stock units vest in four equal annual installments beginning on February 27, 2019. F6 · derivative.expiration_date: Represents a restricted stock unit award granted on February 27, 2018 that partially vested on March 1, 2021. The restricted stock units vest in four equal annual installments beginning on February 27, 2019. Read SEC document
March 01, 2021 Filed Mar 3, 2021 20:30 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionCommon Stock	5,025	$0.00	$0.00	Disclosure SEC source: 0001209191-21-017509 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,091 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document
February 26, 2021 Filed Mar 2, 2021 18:56 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionRestricted Stock Units · Derivative	3,263	$0.00	$0.00	Disclosure SEC source: 0001209191-21-016471 · doc4.xml · derivative · entry 6 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,526 Underlying: Common Stock · 3,263 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F7 · derivative.exercise_date: Represents a restricted stock unit award granted on February 26, 2019 that partially vested on February 26, 2021. The restricted stock units vest in four equal annual installments beginning on February 26, 2020. F7 · derivative.expiration_date: Represents a restricted stock unit award granted on February 26, 2019 that partially vested on February 26, 2021. The restricted stock units vest in four equal annual installments beginning on February 26, 2020. Read SEC document
February 26, 2021 Filed Mar 2, 2021 18:56 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionCommon Stock	3,263	$0.00	$0.00	Disclosure SEC source: 0001209191-21-016471 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document
February 25, 2021 Filed Mar 1, 2021 18:10 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	SaleCommon Stock	6,788	$132.96	$902,532.48	Disclosure SEC source: 0001209191-21-015381 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,301 F1 · shares: The sales reported in this field were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 5,374 shares, Mr. Coward also holds, in the aggregate, an additional 72,757 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document
February 24, 2021 Filed Feb 25, 2021 19:23 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	SaleCommon Stock	6,062	$136.30	$826,250.60	Disclosure SEC source: 0001209191-21-014493 · doc4.xml · nonDerivative · entry 4 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,089 F4 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 23, 2021. F5 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 12,162 shares, Mr. Coward also holds, in the aggregate, an additional 72,757 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document
February 23, 2021 Filed Feb 25, 2021 19:23 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionStock Option (right to buy) · Derivative	18,750	$0.00 Strike: $21.68	$0.00	Disclosure SEC source: 0001209191-21-014493 · doc4.xml · derivative · entry 7 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: These options vested and became exercisable in four equal annual installments beginning on February 23, 2018. F8 · derivative.expiration_date: These options vested and became exercisable in four equal annual installments beginning on February 23, 2018. Read SEC document
February 23, 2021 Filed Feb 25, 2021 19:23 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionRestricted Stock Units · Derivative	12,850	$0.00	$0.00	Disclosure SEC source: 0001209191-21-014493 · doc4.xml · derivative · entry 6 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,850 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F7 · derivative.exercise_date: Represents a restricted stock unit award that partially vested on February 23, 2021. The restricted stock units vest in four equal annual installments beginning on February 23, 2018. F7 · derivative.expiration_date: Represents a restricted stock unit award that partially vested on February 23, 2021. The restricted stock units vest in four equal annual installments beginning on February 23, 2018. Read SEC document
February 23, 2021 Filed Feb 25, 2021 19:23 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	SaleCommon Stock	18,750	$136.51	$2,559,562.50	Disclosure SEC source: 0001209191-21-014493 · doc4.xml · nonDerivative · entry 3 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,151 F3 · shares: The sales reported in this field were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document
February 23, 2021 Filed Feb 25, 2021 19:23 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionCommon Stock	18,750	$21.68	$406,500.00	Disclosure SEC source: 0001209191-21-014493 · doc4.xml · nonDerivative · entry 2 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of common stock received upon exercise of a stock option award. Read SEC document
February 23, 2021 Filed Feb 25, 2021 19:23 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionCommon Stock	12,850	$0.00	$0.00	Disclosure SEC source: 0001209191-21-014493 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,151 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document
February 19, 2021 Filed Feb 23, 2021 18:40 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	GrantRestricted Stock Units · Derivative	8,991	$0.00	$0.00	Disclosure SEC source: 0001209191-21-013406 · doc4.xml · derivative · entry 3 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,991 Underlying: Common Stock · 8,991 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document
February 18, 2021 Filed Feb 22, 2021 18:00 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	SaleCommon Stock	1,980	$140.79	$278,764.20	Disclosure SEC source: 0001209191-21-012834 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,301 F1 · shares: The sales reported in this field were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 5,374 shares, Mr. Coward also holds, in the aggregate, an additional 95,366 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document
February 17, 2021 Filed Feb 18, 2021 19:28 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	SaleCommon Stock	1,992	$142.66	$284,178.72	Disclosure SEC source: 0001209191-21-012159 · doc4.xml · nonDerivative · entry 2 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,281 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 16, 2021. F3 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 7,354 shares, Mr. Coward also holds, in the aggregate, an additional 95,366 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document
February 16, 2021 Filed Feb 18, 2021 19:28 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionRestricted Stock Units · Derivative	3,972	$0.00	$0.00	Disclosure SEC source: 0001209191-21-012159 · doc4.xml · derivative · entry 4 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,916 Underlying: Common Stock · 3,972 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Represents a restricted stock unit award that partially vested on February 16, 2021. The restricted stock units vest in four equal annual installments beginning on February 16, 2021. F5 · derivative.expiration_date: Represents a restricted stock unit award that partially vested on February 16, 2021. The restricted stock units vest in four equal annual installments beginning on February 16, 2021. Read SEC document
February 16, 2021 Filed Feb 18, 2021 19:28 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionCommon Stock	3,972	$0.00	$0.00	Disclosure SEC source: 0001209191-21-012159 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document
March 11, 2019 Filed Mar 12, 2019 17:19 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	SaleCommon Stock	2,774	$87.21	$241,926.09	Disclosure SEC source: 0001209191-19-018887 · doc4.xml · nonDerivative · entry 2 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,096 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on March 9, 2019. F3 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 106,978 shares, Mr. Coward also holds, in the aggregate, an additional 250,212 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document
March 09, 2019 Filed Mar 12, 2019 17:19 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionRestricted Stock Units · Derivative	6,025	$0.00	$0.00	Disclosure SEC source: 0001209191-19-018887 · doc4.xml · derivative · entry 4 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,025 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Represents a restricted stock unit award granted on March 9, 2015 that partially vested on March 9, 2019. The restricted stock units vest in four equal annual installments beginning on March 9, 2016. F5 · derivative.expiration_date: Represents a restricted stock unit award granted on March 9, 2015 that partially vested on March 9, 2019. The restricted stock units vest in four equal annual installments beginning on March 9, 2016. Read SEC document
March 09, 2019 Filed Mar 12, 2019 17:19 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionCommon Stock	6,025	$0.00	$0.00	Disclosure SEC source: 0001209191-19-018887 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document
February 28, 2019 Filed Mar 1, 2019 17:24 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	SaleCommon Stock	2,447	$93.20	$228,070.19	Disclosure SEC source: 0001209191-19-015113 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,845 F1 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 27, 2019. F2 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 103,727 shares, Mr. Coward also holds, in the aggregate, an additional 256,237 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document
February 27, 2019 Filed Feb 28, 2019 20:15 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionRestricted Stock Units · Derivative	5,025	$0.00	$0.00	Disclosure SEC source: 0001209191-19-014805 · doc4.xml · derivative · entry 8 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,075 Underlying: Common Stock · 5,025 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F9 · derivative.exercise_date: Represents a restricted stock unit award granted on February 27, 2018 that partially vested on February 27, 2019. The restricted stock units vest in four equal annual installments beginning on February 27, 2019. F9 · derivative.expiration_date: Represents a restricted stock unit award granted on February 27, 2018 that partially vested on February 27, 2019. The restricted stock units vest in four equal annual installments beginning on February 27, 2019. Read SEC document
February 27, 2019 Filed Feb 28, 2019 20:15 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionCommon Stock	5,025	$0.00	$0.00	Disclosure SEC source: 0001209191-19-014805 · doc4.xml · nonDerivative · entry 3 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,292 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award on February 27, 2019. F4 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 106,174 shares, Mr. Coward also holds, in the aggregate, an additional 256,237 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document
February 27, 2019 Filed Feb 28, 2019 20:15 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	SaleCommon Stock	9,803	$95.07	$932,010.42	Disclosure SEC source: 0001209191-19-014805 · doc4.xml · nonDerivative · entry 2 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,267 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 26, 2019. Read SEC document
February 26, 2019 Filed Feb 28, 2019 20:15 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	GrantRestricted Stock Units · Derivative	13,051	$0.00	$0.00	Disclosure SEC source: 0001209191-19-014805 · doc4.xml · derivative · entry 7 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,051 Underlying: Common Stock · 13,051 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F8 · derivative.exercise_date: These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date. F8 · derivative.expiration_date: These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document
February 26, 2019 Filed Feb 28, 2019 20:15 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	GrantStock Option (right to buy) · Derivative	10,786	$0.00 Strike: $92.62	$0.00	Disclosure SEC source: 0001209191-19-014805 · doc4.xml · derivative · entry 6 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,786 Underlying: Common Stock · 10,786 shares Expires 2029-02-26 F7 · derivative.exercise_date: These options vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document
February 26, 2019 Filed Feb 28, 2019 20:15 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionRestricted Stock Units · Derivative	21,400	$0.00	$0.00	Disclosure SEC source: 0001209191-19-014805 · doc4.xml · derivative · entry 5 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,400 Underlying: Common Stock · 21,400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Represents a restricted stock unit award granted on February 26, 2016 that partially vested on February 26, 2019. The restricted stock units vest in four equal annual installments beginning on February 26, 2017. F6 · derivative.expiration_date: Represents a restricted stock unit award granted on February 26, 2016 that partially vested on February 26, 2019. The restricted stock units vest in four equal annual installments beginning on February 26, 2017. Read SEC document
February 26, 2019 Filed Feb 28, 2019 20:15 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionCommon Stock	21,400	$0.00	$0.00	Disclosure SEC source: 0001209191-19-014805 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award on February 26, 2019. Read SEC document
February 25, 2019 Filed Feb 26, 2019 17:32 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	SaleCommon Stock	6,143	$90.55	$556,254.79	Disclosure SEC source: 0001209191-19-013651 · doc4.xml · nonDerivative · entry 2 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,670 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of restricted stock units on February 23, 2019. F3 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 89,552 shares, Mr. Coward also holds, in the aggregate, an additional 258,825 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document
February 23, 2019 Filed Feb 26, 2019 17:32 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionRestricted Stock Units · Derivative	12,850	$0.00	$0.00	Disclosure SEC source: 0001209191-19-013651 · doc4.xml · derivative · entry 4 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,700 Underlying: Common Stock · 12,850 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Represents a restricted stock unit award granted on February 23, 2017 that partially vested on February 23, 2019. The restricted stock units vest in four equal annual installments beginning on February 23, 2018. F5 · derivative.expiration_date: Represents a restricted stock unit award granted on February 23, 2017 that partially vested on February 23, 2019. The restricted stock units vest in four equal annual installments beginning on February 23, 2018. Read SEC document
February 23, 2019 Filed Feb 26, 2019 17:32 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionCommon Stock	12,850	$0.00	$0.00	Disclosure SEC source: 0001209191-19-013651 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,813 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award on February 23, 2019. Read SEC document
January 24, 2019 Filed Jan 25, 2019 18:47 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	SaleCommon Stock	6,800	$79.31	$539,280.80	Disclosure SEC source: 0001209191-19-005425 · doc4.xml · nonDerivative · entry 4 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,963 F2 · shares: The sales reported in this field were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.09 to $79.515, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote 5 to this Form 4. F6 · balance_after: In addition to the shares of Common Stock reported on this Form 4, Mr. Coward also holds, in the aggregate, an additional 271,675 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document
January 24, 2019 Filed Jan 25, 2019 18:47 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	SaleCommon Stock	99,231	$78.40	$7,780,107.32	Disclosure SEC source: 0001209191-19-005425 · doc4.xml · nonDerivative · entry 3 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,763 F2 · shares: The sales reported in this field were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.03 to $79.02, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote 4 to this Form 4. Read SEC document
January 24, 2019 Filed Jan 25, 2019 18:47 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	SaleCommon Stock	63,078	$77.79	$4,906,837.62	Disclosure SEC source: 0001209191-19-005425 · doc4.xml · nonDerivative · entry 2 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,994 F2 · shares: The sales reported in this field were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.03 to $78.025, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote 3 to this Form 4. Read SEC document
January 23, 2019 Filed Jan 25, 2019 18:47 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionPerformance Share Units · Derivative	169,109	$0.00	$0.00	Disclosure SEC source: 0001209191-19-005425 · doc4.xml · derivative · entry 6 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 169,109 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each Performance Share Unit represents a right to receive one share of common stock. F8 · derivative.exercise_date: The PSU Award was subject to certain performance-based vesting requirements tied to the growth in the Company's stock price through the three-year period ending December 31, 2018 (the "Performance Period") as calculated by reference to the 20 trading day trailing average closing price of the Company's common stock (the "Stock Price") as of the last day of the Performance Period compared to such Stock Price as of the beginning of the Performance Period. The Stock Price as of the last day of the Performance Period was $67.25 representing a greater than 760% increase from the $8.85 Stock Price at the beginning of the Performance Period. At target, the PSU Award covered 112,740 PSUs. Because the Stock Price at the end of the Performance Period well exceeded the maximum target Stock Price, the reporting person earned the maximum number of PSUs to which he was entitled under the PSU Award. The PSUs vested on January 2, 2019 and settled into shares of Common Stock on January 23, 2019. F8 · derivative.expiration_date: The PSU Award was subject to certain performance-based vesting requirements tied to the growth in the Company's stock price through the three-year period ending December 31, 2018 (the "Performance Period") as calculated by reference to the 20 trading day trailing average closing price of the Company's common stock (the "Stock Price") as of the last day of the Performance Period compared to such Stock Price as of the beginning of the Performance Period. The Stock Price as of the last day of the Performance Period was $67.25 representing a greater than 760% increase from the $8.85 Stock Price at the beginning of the Performance Period. At target, the PSU Award covered 112,740 PSUs. Because the Stock Price at the end of the Performance Period well exceeded the maximum target Stock Price, the reporting person earned the maximum number of PSUs to which he was entitled under the PSU Award. The PSUs vested on January 2, 2019 and settled into shares of Common Stock on January 23, 2019. Read SEC document
January 23, 2019 Filed Jan 25, 2019 18:47 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionCommon Stock	169,109	$0.00	$0.00	Disclosure SEC source: 0001209191-19-005425 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,072 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon settlement of a performance share unit award (the "PSU Award") on January 23, 2019, which is described further in Footnote 7 to this Form 4. Read SEC document
January 03, 2019 Filed Jan 4, 2019 16:56 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	SaleCommon Stock	1,581	$62.75	$99,214.07	Disclosure SEC source: 0001209191-19-002046 · doc4.xml · nonDerivative · entry 2 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,963 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on December 31, 2018. Read SEC document
January 02, 2019 Filed Jan 4, 2019 16:56 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	GrantPerformance Share Units · Derivative	169,109	$0.00	$0.00	Disclosure SEC source: 0001209191-19-002046 · doc4.xml · derivative · entry 5 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,109 Underlying: Common Stock · 169,109 shares Expires not disclosed F5 · security: Represents a PSU award granted on February 26, 2016 (the "PSU Award") which covered a three-year performance measurement period ending on December 31, 2018 (the "Performance Period") and was described in the Company's proxy statement filed with the Securities and Exchange Commission on April 28, 2017. F6 · derivative.exercise_price: Each Performance Share Unit represents a right to receive one share of common stock. F7 · derivative.exercise_date: The PSU Award was subject to certain performance-based vesting requirements tied to the growth in the Company's stock price through the end of the Performance Period as calculated by reference to the 20 trading day trailing average closing price of the Company's common stock (the "Stock Price") as of the last day of the Performance Period compared to such Stock Price as of the beginning of the Performance Period. The Stock Price as of the last day of the Performance Period was $67.25 representing a greater than 760% increase from the $8.85 Stock Price at the beginning of the Performance Period. At target, the PSU Award covered 112,740 PSUs. Because the Stock Price at the end of the Performance Period well exceeded the maximum target Stock Price, the reporting person earned the maximum number of PSUs to which he was entitled under the PSU Award. The PSUs are immediately vested and will settle into shares of Common Stock within 30 days from the date of issuance. F7 · derivative.expiration_date: The PSU Award was subject to certain performance-based vesting requirements tied to the growth in the Company's stock price through the end of the Performance Period as calculated by reference to the 20 trading day trailing average closing price of the Company's common stock (the "Stock Price") as of the last day of the Performance Period compared to such Stock Price as of the beginning of the Performance Period. The Stock Price as of the last day of the Performance Period was $67.25 representing a greater than 760% increase from the $8.85 Stock Price at the beginning of the Performance Period. At target, the PSU Award covered 112,740 PSUs. Because the Stock Price at the end of the Performance Period well exceeded the maximum target Stock Price, the reporting person earned the maximum number of PSUs to which he was entitled under the PSU Award. The PSUs are immediately vested and will settle into shares of Common Stock within 30 days from the date of issuance. Read SEC document
January 02, 2019 Filed Jan 4, 2019 16:56 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionRestricted Stock Units · Derivative	4,687	$0.00	$0.00	Disclosure SEC source: 0001209191-19-002046 · doc4.xml · derivative · entry 4 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,687 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Represents a restricted stock unit award granted on January 1, 2015 that partially vested on December 31, 2018 and which shares were delivered on January 2, 2019. The restricted stock units vest as follows: one-quarter on the first anniversary of the grant date and the balance in equal quarterly installments over the three year period beginning on the one-year anniversary of the grant date. F4 · derivative.expiration_date: Represents a restricted stock unit award granted on January 1, 2015 that partially vested on December 31, 2018 and which shares were delivered on January 2, 2019. The restricted stock units vest as follows: one-quarter on the first anniversary of the grant date and the balance in equal quarterly installments over the three year period beginning on the one-year anniversary of the grant date. Read SEC document
January 02, 2019 Filed Jan 4, 2019 16:56 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionCommon Stock	4,687	$0.00	$0.00	Disclosure SEC source: 0001209191-19-002046 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,544 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award on December 31, 2018 and delivered on January 2, 2019. Read SEC document
October 01, 2018 Filed Oct 2, 2018 16:28 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	SaleCommon Stock	2,190	$79.51	$174,118.14	Disclosure SEC source: 0001209191-18-053144 · doc4.xml · nonDerivative · entry 2 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,857 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on September 30, 2018. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.